Pfizer Answers Critics with New Rx


 
Pfizer Answers Critics with New Rx

During a meeting with industry analysts, Pfizer said it intends to expand in emerging markets. It also said that it will establish a new business unit focusing on cancer drugs, and that it aims to significantly boost the number of drugs in late-stage trials by late next year. The company said it plans to seek 15–20 regulatory approvals between 2010 and 2012. Reuters (3/5)

 

Can Pfizer Deliver a New Prescription?

Though Jeffrey Kindler took over Pfizer’s reins less than 2 years ago, investors are becoming restless. Despite high expectations that Kindler—who came in as a relative outsider—will revitalize the company via fresh initiatives, Pfizer’s stock is down almost 15% since he took over. The company will have to compensate for the loss of about $13 billion of annual Lipitor (atorvastatin) revenue when it goes off patent—perhaps as soon as 2010. The Wall Street Journal (Subscription required) (3/4)

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Reverse Informatics logo
The Fourth Paradigm of Science
Sponsored by Reverse Informatics


liaison logo
Managing and Integrating Clinical Trial Data:
A Challenge for Pharma and their CRO Partners
Sponsored by Liaison Healthcare Informatics


Life Science Webcasts & Podcasts

medidata_podcast_Sites and Sponsors: Mending Bridges over Troubled Waters  
Sites and Sponsors: Mending Bridges over Troubled Waters
Sponsored by Medidata Solutions Worldwide

This podcast brings together two industry leaders to focus on the issues that divide sponsors and sites. On the one hand sites and sponsors unite in advancing better health care through a common passion for developing better drugs. Yet some issues divide them and bridges need to be built or mended to advance the highest levels of cooperation, coordination and success in clinical trials. Listen as the key issues are debated from the site and the sponsor side and new methods and technology are advanced that offer near-term and lasting solutions.

• Common ground in reaching agreement on a budget

• Improving the pace of agreement on budgets and contracts

• Processes for payment to sites on a timely basis

Listen Now  

More Podcasts

Job Openings

Sponsored Links

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.